Therapeutic factors secreted by mesenchymal stromal cells and tissue repair

Journal of Cellular Biochemistry

Volumn 112, Issue 11, 2011, Pages 3073-3078

  Lee, Ryang Hwa ^a   Oh, Joo Youn ^a   Choi, Hosoon ^a   Bazhanov, Nikolay ^a  

^a Texas Agricultural and Mechanical   (United States)

Author keywords

ADULT PROGENITOR CELLS; MSCs; SECRETORY FACTORS

Indexed keywords

ANTIINFLAMMATORY AGENT; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; HLA G ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NITRIC OXIDE; PEPTIDES AND PROTEINS; PROSTAGLANDIN E2; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA STIMULATED GENE 6 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BRAIN INJURY; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CORNEA OPACITY; CYTOLYSIS; CYTOTOXICITY; DIABETES MELLITUS; ENCEPHALITIS; ENVIRONMENTAL STRESS; GENE EXPRESSION; GRAFT SURVIVAL; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; LUNG INJURY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORGAN TRANSPLANTATION; PERITONITIS; PREGNANCY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STEM CELL; STROKE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; TISSUE REPAIR; UPREGULATION;

APOPTOSIS; HUMANS; INFLAMMATION; MESENCHYMAL STROMAL CELLS; REGENERATION; WOUND HEALING;

ANIMALIA;

EID: 80054971047     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23250     Document Type: Article

References (61)

1. Angoulvant D, Ivanes F, Ferrera R, Matthews PG, Nataf S, Ovize M,. 2011. Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant 30: 95-102;.
2. Bakondi B, Shimada IS, Peterson BM, Spees JL,. 2011. SDF-1alpha secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7. Stem Cells Dev 20: 1021-1029;.
3. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R,. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48;. (Pubitemid 34059216)
4. Bartosh TJ, Ylostalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, Lee RH, Choi H, Prockop DJ,. 2010. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci USA 107: 13724-13729;.
5. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, DiMattia G, Sullivan DE, Prockop DJ,. 2009. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 27: 670-681;.
6. Bouffi C, Bony C, Courties G, Jorgensen C, Noel D,. 2010. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 5: e14247.
7. Caplan AI,. 2009. Why are MSCs therapeutic? New data: New insight. J Pathol 217: 318-324;.
8. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M,. 2003. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J.Neurosci Res 73: 778-786;. (Pubitemid 37071731)
9. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ,. 2011. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-{kappa}B signaling in resident macrophages. Blood 118: 330-338;.
10. Deng YB, Ye WB, Hu ZZ, Yan Y, Wang Y, Takon BF, Zhou GQ, Zhou YF,. 2010. Intravenously administered BMSCs reduce neuronal apoptosis and promote neuronal proliferation through the release of VEGF after stroke in rats. Neurol Res 32: 148-156;.
11. Dexter TM, Allen TD, Lajtha LG,. 1977. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91: 335-344;. (Pubitemid 8112206)
12. Docheva D, Haasters F, Schieker M,. 2008. Mesenchymal stem cells and their cell surface receptors. Curr Rheumatol Rev 4: 155-160;.
13. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E,. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317;. (Pubitemid 44269669)
14. English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP,. 2009. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol 156: 149-160;.
15. Ge W, Jiang J, Arp J, Liu W, Garcia B, Wang H,. 2010. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 90: 1312-1320;.
16. Gieseke F, Schutt B, Viebahn S, Koscielniak E, Friedrich W, Handgretinger R, Muller I,. 2007. Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood 110: 2197-2200;. (Pubitemid 47443941)
17. Groh ME, Maitra B, Szekely E, Koc ON,. 2005. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33: 928-934;. (Pubitemid 40982660)
18. Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, Abbate M, Zoja C, Remuzzi G,. 2007. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18: 2921-2928;. (Pubitemid 350058399)
19. Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, Sobel BE, Delafontaine P, Prockop DJ,. 2007. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354: 700-706;. (Pubitemid 46186241)
20. Ivanova-Todorova E, Mourdjeva M, Kyurkchiev D, Bochev I, Stoyanova E, Dimitrov R, Timeva T, Yunakova M, Bukarev D, Shterev A, Tivchev P, Kyurkchiev S,. 2009. HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am J Reprod Immunol 62: 25-33;.
21. Kopen GC, Prockop DJ, Phinney DG,. 1999. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96: 10711-10716;. (Pubitemid 29442209)
22. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O,. 2003. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57: 11-20;. (Pubitemid 38019084)
23. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA,. 2009a. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 106: 16357-16362;.
24. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ,. 2009b. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5: 54-63;.
25. Liang X, Su YP, Kong PY, Zeng DF, Chen XH, Peng XG, Zou ZM, Xu H,. 2010. Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro. Int J Radiat Biol 86: 230-237;.
26. Mackenzie TC, Flake AW,. 2001. Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27: 601-604;. (Pubitemid 32757054)
27. Matysiak M, Orlowski W, Fortak-Michalska M, Jurewicz A, Selmaj K,. 2011. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J Neuroimmunol 233: 106-111;.
28. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D,. 2004. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621;. (Pubitemid 38745993)
29. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS,. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834;.
30. Mougiakakos D, Jitschin R, Johansson CC, Okita R, Kiessling R, Le Blanc K,. 2011. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117: 4826-4835;.
31. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ,. 2005. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A 102: 18171-18176;. (Pubitemid 41798520)
32. Najar M, Raicevic G, Boufker HI, Fayyad Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L,. 2010. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cell Immunol 264: 171-179;.
33. Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N, Sensebe L, Zhang Y, Gorin NC, Thierry D, Fouillard L,. 2007a. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 13: 217-226;. (Pubitemid 47024153)
34. Nasef A, Mathieu N, Chapel A, Frick J, Francois S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L,. 2007b. Immunosuppressive effects of mesenchymal stem cells: Involvement of HLA-G. Transplantation 84: 231-237;. (Pubitemid 47205757)
35. Nasef A, Mazurier C, Bouchet S, Francois S, Chapel A, Thierry D, Gorin NC, Fouillard L,. 2008. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol 253: 16-22;.
36. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E,. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49;.
37. Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bundoc VG, Hodges MG, Jelinek I, Madala S, Karpati S, Mezey E,. 2010. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 107: 5652-5657;.
38. Oh JY, Roddy GW, Choi H, Lee RH, Ylostalo JH, Rosa RH, Jr., Prockop DJ,. 2010. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci USA 107: 16875-16880;.
39. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG,. 2007. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007;. (Pubitemid 47175216)
40. Popp FC, Eggenhofer E, Renner P, Slowik P, Lang SA, Kaspar H, Geissler EK, Piso P, Schlitt HJ, Dahlke MH,. 2008. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 20: 55-60;.
41. Prockop DJ,. 2009. Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol Ther 17: 939-946;.
42. Prockop DJ, Kota DJ, Bazhanov N, Reger RL,. 2010. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med 14: 2190-2199;.
43. Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, Basik M, Galipeau J,. 2009. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J Immunol 182: 5994-6002;.
44. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y,. 2008. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150;. (Pubitemid 351181031)
45. Roddy GW, Oh JY, Lee RH, Bartosh TJ, Ylostalo J, Coble K, Rosa RH, Prockop DJ,. Manuscript under revision.
46. Ryan JM, Barry F, Murphy JM, Mahon BP,. 2007. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149: 353-363;. (Pubitemid 47063057)
47. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P,. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336;. (Pubitemid 47592917)
48. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K,. 2007. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109: 228-234;. (Pubitemid 46053063)
49. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F,. 2008. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26: 212-222;.
50. Semont A, Mouiseddine M, Francois A, Demarquay C, Mathieu N, Chapel A, Sache A, Thierry D, Laloi P, Gourmelon P,. 2010. Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ 17: 952-961;.
51. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ,. 2002. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 73: 1919-1925;; discussion 1926.
52. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M,. 2006. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24: 74-85;.
53. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L,. 2008. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111: 1327-1333;. (Pubitemid 351213419)
54. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L,. 2009. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2. Blood 113: 6576-6583;.
55. Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X, Guo LY, Chen L, Huang YZ, Wan Y, Chen SY,. 2011. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res.
56. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C,. 2007. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292: F1626-1635;. (Pubitemid 46701891)
57. Tsubokawa T, Yagi K, Nakanishi C, Zuka M, Nohara A, Ino H, Fujino N, Konno T, Kawashiri MA, Ishibashi-Ueda H, Nagaya N, Yamagishi M,. 2010. Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am J Physiol Heart Circ Physiol 298: H1320-1329;.
58. Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML,. 2010. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 43: 255-263;.
59. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, Masuda J, Kobayashi S, Kim SU, Yamaguchi S,. 2010. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res 88: 1017-1025;.
60. Wang F, Yasuhara T, Shingo T, Kameda M, Tajiri N, Yuan WJ, Kondo A, Kadota T, Baba T, Tayra JT, Kikuchi Y, Miyoshi Y, Date I,. 2010. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci 11: 52.
61. Yu XY, Geng YJ, Li XH, Lin QX, Shan ZX, Lin SG, Song YH, Li Y,. 2009. The effects of mesenchymal stem cells on c-kit up-regulation and cell-cycle re-entry of neonatal cardiomyocytes are mediated by activation of insulin-like growth factor 1 receptor. Mol Cell Biochem 332: 25-32;.